HEPA CIK: 1583771

Hepion Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
97.5
FY22:
56.5
FY23:
17.5
FY24:
1.61
FY25:
3.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.10
FY22:
3.75
FY23:
0.61
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
104
FY22:
60.2
FY23:
18.1
FY24:
1.61
FY25:
3.07

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
8.21
FY22:
7.89
FY23:
5.29
FY24:
3.14
FY25:
0.30
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.35
FY22:
2.50
FY23:
5.52
FY24:
0.33
FY25:
0.10
(positive)
Change from FY21 to FY25
millions USD
FY21:
93.0
FY22:
49.9
FY23:
7.28
FY24:
−1.86
FY25:
2.67
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
104
FY22:
60.2
FY23:
18.1
FY24:
1.61
FY25:
3.07

All amounts in millions USD Data source:SEC EDGAR